Applied Therapeutics, Inc. APLT
Set alert
0.10 USD 0.00 0.00%
At close · Jul 2
0.11 0.00 +2.04%
After hours · Jul 2, 4:00 PM ET
0.103 Day range 0.103
0.78 52-week range 10.62
- YTD
- +3.00%
- 1 year
- -81.62%
- Open
- 0.103
- Prev close
- 0.103
- Mkt cap
- 99.09M
- Vol
- 0
- Avg vol
- 5.16M
- EPS
- -1.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.103
- High
- 0.103
- Forward P/E
- -1.85
- Beta
- 2.02
- Short ratio
- 3.25
- Inst. own
- 103.35%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 6.47
- 200-d avg
- 5.81
- 1y target
- 5.92
Financial health
Altman Z-Score
-27.42 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.1×
FY 2017 5y median -2.2× FY 2024
P/S 263×
FY 2017 5y median 0.0× FY 2024
P/B 2.1×
FY 2017 5y median 3.7× FY 2024
P/FCF -1.4×
FY 2017 5y median -2.5× FY 2024
EV/EBITDA -0.4×
FY 2017 5y median -1.7× FY 2024
EV/Sales 94.2×
FY 2017 5y median 0.0× FY 2024
FCF Yield -70.6%
FY 2017 5y median -39.6% FY 2024
Profitability
Gross Margin -10613.0%
FY 2017 5y median 0.0% FY 2024
Operating Margin -22922.9%
FY 2017 5y median 0.0% FY 2024
Net Margin -23214.1%
FY 2017 5y median 0.0% FY 2024
ROE -185.3%
FY 2017 5y median -168.8% FY 2024
ROIC -174.4%
FY 2017 5y median -163.3% FY 2024
ROA -121.8%
FY 2017 5y median -121.8% FY 2024
Growth (YoY)
Revenue -95.4%
FY 2017 FY 2024
Operating Income -61.6%
FY 2017 FY 2024
EPS (diluted) 46.5%
FY 2017 FY 2024
Free Cash Flow -52.8%
FY 2017 FY 2024
Financial Health
Current Ratio 3.1×
FY 2017 5y median 3.1× FY 2024
Quick Ratio 3.1×
FY 2017 5y median 3.1× FY 2024
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2024
Net Debt / EBITDA 0.7×
FY 2017 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31